Winfast Holding is the famous VC, which was founded in 2003. The main department of described VC is located in the Shanghai. The venture was found in Asia in China.
The usual cause for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are Dyee Capital.
The high activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars.
Among the most popular portfolio startups of the fund, we may highlight Borns Robot. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. Among the most successful fund investment fields, there are Cosmetic Surgery, Medical Device.
Related Funds
Fund Name | Location |
8point Capital | - |
Amber Group | China, Hong Kong, Hong Kong Island |
Avios Group | Crawley, United Kingdom, West Sussex |
Dickey Revocable Living Trust | - |
Essex Bio-Technology | China, Hong Kong, Hong Kong Island |
FX Venture | - |
Global Logistic Properties | Central Region, Singapore, Singapore |
Government Savings Bank | - |
North Coast Angel Fund | Cleveland, Ohio, United States |
Ride On Express Holdings | Japan, Tokyo |
Scala | Malvern, Pennsylvania, United States |
Sorrento Therapeutics | California, San Diego, United States |
Startup Canada | Canada, Ontario, Ottawa |
TAIHO Industrial | Japan, Kagawa Prefecture, Takamatsu |
The Mortgage Collaborative | California, San Diego, United States |
VDOSH | California, Encino, United States |
Voima Ventures | Finland, Helsinki, Southern Finland |
Wenshi Touzi | China, Shanghai |
Western Financial Group | Alberta, Canada, High River |
Zing Capital | United States, Vancouver, Washington |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Zhiren Jingxing | $15M | 26 Jan 2024 | Nanjing, Jiangsu, China | ||
UniXell | $30M | 14 Mar 2022 | Shanghai, Shanghai, China | ||
TOPI Imaging Technology | $30M | 14 Dec 2021 | Beijing, Beijing, China | ||
Huasun Energy | 01 Nov 2021 | Hefei, Anhui, China | |||
Haihe Biopharma | $185M | 24 Jul 2020 | Shanghai, China | ||
$278M | 29 Apr 2020 | China, Shanghai | |||
$15M | 09 Apr 2018 | China, Wuwei | |||
$463K | 01 Feb 2016 | China, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Zhiren Jingxing | $15M | 26 Jan 2024 | Nanjing, Jiangsu, China | ||
UniXell | $30M | 14 Mar 2022 | Shanghai, Shanghai, China | ||
TOPI Imaging Technology | $30M | 14 Dec 2021 | Beijing, Beijing, China | ||
Huasun Energy | 01 Nov 2021 | Hefei, Anhui, China | |||
Haihe Biopharma | $185M | 24 Jul 2020 | Shanghai, China | ||
$278M | 29 Apr 2020 | China, Shanghai | |||
$15M | 09 Apr 2018 | China, Wuwei | |||
$463K | 01 Feb 2016 | China, Zhejiang |